Medical Science Liaison, Uk - London, United Kingdom - Exact Sciences Corporation
Description
Help us change lives
At Exact Sciences, we're helping change how the world prevents, detects and guides treatment for cancer. We give patients and clinicians the clarity needed to make confident decisions when they matter most.
Join our team to find a purpose-driven career, an inclusive culture, and robust benefits to support your life while you're working to help others.
Company Overview
Exact Sciences is dedicated to delivering patient critical answers across the cancer journey from early detection to treatment decision making.
With a strong focus on people and an empathetic spirit, which fuels the company's culture, driving them to create and deliver solutions rooted in the needs of patients, providers, and families.
From earlier cancer detection to treatment guidance and monitoring, Exact Sciences are helping people get the answers they need to make more informed decisions across the cancer continuum.
With a leading portfolio of products for earlier detection and treatment guidance, they help people face the most challenging decisions with confidence with a dedication to continuously innovate, combining scientific rigor with an open-minded approach to deliver the next big thing.
Exact Sciences is continuously expanding the pipeline with the aim of tackling a wider array of cancer tests through the following measures:- Expanding the Oncotype IQ platform to include liquid and tissue-based tests, all with the goal of making cancer care smarter.
- Adapting biomarkerbased technologies create a liquid biopsy capable of detecting cancers and precancers from a blood sample.
- Using their proven multimarker approach to achieve analytical sensitivity needed to discriminate between normal and cancerous samples.
- Collaborating with worldclass clinicians and scientists at Mayo Clinic to identify biomarkers associated with the 15 deadliest cancers.
- Building a cancer detection platform upon learnings from the development of Cologuard (commercially available in the US only).
By 2020, Oncotype DX will have been used to guide treatment decisions for more than 1 million cancer patients worldwide in breast, prostate and colon cancer.
In July 2019 Exact Sciences acquired Genomic Health, a genetic cancer detection company based in Redwood City, California, for USD 2.8 billion, creating the leading global cancer diagnostics company.
In 2020 Exact Sciences acquired Thrive Earlier Detection Corp., a Massachusetts-based healthcare company, in a multi-billion-dollar deal, and Base Genomics, which has technology for DNA methylation analysis.
In February 2021 Exact Sciences announced the acquisition of Ashion Analytics, LLC (Ashion) from The Translational Genomics Research Institute (TGen), an affiliate of City of Hope.
Ashion is a CLIA-certified and CAP-accredited sequencing lab based in Phoenix, Arizona with the genomics testing capabilities necessary to address the increasingly complex needs of clinical, academic, and biopharma customers focused on precision cancer treatments.
The company is based in the United States, with International headquarters in Zug, Switzerland.Position Summary
Representing the medical function, the MSL will act as a medical/clinical education liaison to external and internal stakeholders, while supporting commercial business and reimbursement objectives for the portfolio of products, most notably for breast and colorectal cancers.
This role will engage with customers and colleagues across medical affairs and commercial groups to provide medical and scientific support for our on-market as well as help launch newer products into the international region.
Near term business objectives include supporting growth of the Oncotype DX Breast Recurrence Score assay by providing medical information and education through scientific exchange in a fair-balanced manner to Medical Oncology, Surgeons, and Pathology Key Opinion Leaders as well as other healthcare professionals.
In addition, the role supports the company's R&D and investigator-initiated studies in the development and commercialization of genomic assays that lead to improved treatment decisions for oncology patients.
To be an effective business partner MSLs develop and maintain outstanding knowledge of Exact Sciences products, competitor products, and other diagnostic options within therapeutic areas.
MSLs must also maintain an in-depth understanding of the medical strategy and broader Exact Sciences strategy to ensure their own activities are coordinated and aligned.
MSLs must be professionals with integrity and scientific creditability to interact with thought leaders, government health authorities, and medical centers of excellence.
Responsibilities/Duties
Include, but are not limited to, the following:
Inline Product & Team Support- Deliver education of the broad healthcare provider (HCP) community, such as key opinion leaders (KOL's), oncologists, pathologists, surgeons, nurses, and payo
